285 related articles for article (PubMed ID: 8666230)
1. Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells.
Kieser A; Seitz T; Adler HS; Coffer P; Kremmer E; Crespo P; Gutkind JS; Henderson DW; Mushinski JF; Kolch W; Mischak H
Genes Dev; 1996 Jun; 10(12):1455-66. PubMed ID: 8666230
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2.
Kortenjann M; Thomae O; Shaw PE
Mol Cell Biol; 1994 Jul; 14(7):4815-24. PubMed ID: 8007980
[TBL] [Abstract][Full Text] [Related]
3. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.
Cook SJ; Aziz N; McMahon M
Mol Cell Biol; 1999 Jan; 19(1):330-41. PubMed ID: 9858557
[TBL] [Abstract][Full Text] [Related]
4. The induction of Egr-1 expression by v-Fps is via a protein kinase C-independent intracellular signal that is sequentially dependent upon HaRas and Raf-1.
Alexandropoulos K; Qureshi SA; Bruder JT; Rapp U; Foster DA
Cell Growth Differ; 1992 Oct; 3(10):731-7. PubMed ID: 1332742
[TBL] [Abstract][Full Text] [Related]
5. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
6. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
7. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
[TBL] [Abstract][Full Text] [Related]
8. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes.
McCarthy SA; Samuels ML; Pritchard CA; Abraham JA; McMahon M
Genes Dev; 1995 Aug; 9(16):1953-64. PubMed ID: 7649477
[TBL] [Abstract][Full Text] [Related]
9. A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation.
Dhillon AS; Meikle S; Peyssonnaux C; Grindlay J; Kaiser C; Steen H; Shaw PE; Mischak H; Eychène A; Kolch W
Mol Cell Biol; 2003 Mar; 23(6):1983-93. PubMed ID: 12612072
[TBL] [Abstract][Full Text] [Related]
10. An inhibitory Raf-1 mutant suppresses expression of a subset of v-raf-activated genes.
Miltenberger RJ; Cortner J; Farnham PJ
J Biol Chem; 1993 Jul; 268(21):15674-80. PubMed ID: 8340392
[TBL] [Abstract][Full Text] [Related]
11. PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells.
Su Z; Shi Y; Friedman R; Qiao L; McKinstry R; Hinman D; Dent P; Fisher PB
Nucleic Acids Res; 2001 Apr; 29(8):1661-71. PubMed ID: 11292838
[TBL] [Abstract][Full Text] [Related]
12. Evidence that activation of the Egr-1 promoter by v-Raf involves serum response elements.
Rim M; Qureshi SA; Gius D; Nho J; Sukhatme VP; Foster DA
Oncogene; 1992 Oct; 7(10):2065-8. PubMed ID: 1408148
[TBL] [Abstract][Full Text] [Related]
13. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
Seternes OM; Johansen B; Moens U
Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
[TBL] [Abstract][Full Text] [Related]
14. Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element.
Soh JW; Lee EH; Prywes R; Weinstein IB
Mol Cell Biol; 1999 Feb; 19(2):1313-24. PubMed ID: 9891065
[TBL] [Abstract][Full Text] [Related]
15. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
Fukasawa K; Vande Woude GF
Mol Cell Biol; 1997 Jan; 17(1):506-18. PubMed ID: 8972231
[TBL] [Abstract][Full Text] [Related]
16. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells.
Hagemann D; Troppmair J; Rapp UR
Oncogene; 1999 Feb; 18(7):1391-400. PubMed ID: 10050876
[TBL] [Abstract][Full Text] [Related]
17. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
18. Transformation-specific pattern of phosphorylation of c-Jun, Jun-B, Jun-D and Egr-1 in v-sis transformed cells.
Grover-Bardwick A; Adamson E; Mercola D
Carcinogenesis; 1994 Aug; 15(8):1667-74. PubMed ID: 8055649
[TBL] [Abstract][Full Text] [Related]
19. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.
Schönwasser DC; Marais RM; Marshall CJ; Parker PJ
Mol Cell Biol; 1998 Feb; 18(2):790-8. PubMed ID: 9447975
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells.
Weissinger EM; Eissner G; Grammer C; Fackler S; Haefner B; Yoon LS; Lu KS; Bazarov A; Sedivy JM; Mischak H; Kolch W
Mol Cell Biol; 1997 Jun; 17(6):3229-41. PubMed ID: 9154822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
